Why is Remedium Life falling/rising?

As of 12-Sep, Remedium Lifecare Ltd's stock price is currently at 1.52, showing no change (0.00%). The stock has outperformed its sector today by 0.71%, and it is trading higher than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below its 200-day moving average. Over the past week, the stock has increased by 5.56%, and in the last month, it has risen by 14.29%. However, the company has reported significant losses, with a negative return on capital employed (ROCE) and a high debt-to-EBITDA ratio of -1.00 times, indicating a low ability to service debt. Additionally, the company has declared negative results for the last four consecutive quarters, with net sales falling by 76.36%, which negatively impacts investor sentiment.
In the broader market context, the stock's performance over the past year has been notably poor, with a decline of 77.46%, while the benchmark Sensex has only fallen by 1.28%. Despite the recent short-term gains, the long-term outlook remains bleak due to the company's poor financial health and negative EBITDA. The stock's liquidity is adequate for trading, but the overall risk associated with the company's financial instability suggests that the recent price movements may not be sustainable in the long run.